Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Classification of Systems-I01:26

Classification of Systems-I

Linearity is a system property characterized by a direct input-output relationship, combining homogeneity and additivity.
Homogeneity dictates that if an input x(t) is multiplied by a constant c, the output y(t) is multiplied by the same constant. Mathematically, this is expressed as:
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same author

Multivariate Random Forests for Cross-Modal Multi-Omics Integration.

bioRxiv : the preprint server for biology·2026
Same author

Longitudinal Blood DNA Methylation Changes During Weight-Loss Intervention and Dementia Progression Risk.

Research square·2026
Same author

From aging to Alzheimer's disease: concordant brain DNA methylation changes in late life.

Genome medicine·2026
Same author

A Lasting Legacy: Long-Term Effects of Exercise Training on Cardiometabolic Health in the STRRIDE-Prediabetes Reunion Study.

medRxiv : the preprint server for health sciences·2026
Same author

MethylCog predicts six-year cognitive ability beyond blood-based ADRD biomarkers.

medRxiv : the preprint server for health sciences·2026

Related Experiment Videos

A comprehensive comparison of random forests and support vector machines for microarray-based cancer classification.

Alexander Statnikov1, Lily Wang, Constantin F Aliferis

  • 1Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA. alexander.statnikov@vanderbilt.edu

BMC Bioinformatics
|July 24, 2008
PubMed
Summary

Support vector machines (SVMs) outperform random forests for gene expression microarray data classification. Rigorous evaluation shows SVMs are superior for cancer diagnosis and outcome prediction, highlighting the importance of robust bioinformatics algorithm comparison.

Related Experiment Videos

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Gene expression microarrays are crucial for cancer diagnosis and outcome prediction.
  • Accurate classification algorithms are essential for developing effective molecular signatures.
  • Support vector machines (SVMs) are established as top-tier algorithms, but recent studies suggest random forests may be superior.

Purpose of the Study:

  • To rigorously evaluate and compare the performance of random forest and support vector machine algorithms for microarray data classification.
  • To identify and correct methodological biases in prior comparative studies.
  • To provide a reliable benchmark for bioinformatics algorithm selection in clinical applications.

Main Methods:

  • A rigorous evaluation of random forests and support vector machines was conducted.
  • Twenty-two diagnostic and prognostic gene expression microarray datasets were used.
  • The study corrected for methodological biases present in previous comparative analyses.

Main Results:

  • Support vector machines (SVMs) consistently outperformed random forests across the majority of datasets.
  • The performance advantage of SVMs was significant in most comparisons.
  • The importance of sound research design in benchmarking bioinformatics algorithms was underscored.

Conclusions:

  • Support vector machines (SVMs) demonstrate superior performance compared to random forests for microarray data analysis.
  • This finding holds true both with and without the application of gene selection methods.
  • The results emphasize the continued relevance of SVMs in clinical bioinformatics for patient care.